|
HS Code |
911474 |
| Name | Bile Arisaema |
| Other Names | Dan Nan Xing |
| Type | Traditional Chinese Medicine |
| Origin | China |
| Main Ingredient | Rhizome of Arisaema erubescens treated with bovine bile |
| Appearance | Yellowish-brown powder or granules |
| Taste | Bitter |
| Primary Use | Phlegm-resolving and convulsion-relieving |
| Traditional Category | Herbal medicine, processed herb |
| Storage Conditions | Keep in a cool, dry place |
| Dosage Form | Powder or sliced herb |
| Common Administration Route | Oral |
| Used For | Wind-phlegm, epilepsy, stroke, convulsions |
| Processing Method | Fermentation with cow bile |
As an accredited Bile Arisaema factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Bile Arisaema is packaged in a 100g sealed, silver foil pouch with clear labeling, storage instructions, and lot number. |
| Shipping | Bile Arisaema is shipped in tightly sealed, moisture-resistant containers to ensure product stability and quality. Packages are labeled according to regulatory requirements for chemical safety. Transport is typically via ground or air freight, with temperature and handling monitored to prevent contamination or degradation during transit. Documentation accompanies each shipment for traceability. |
| Storage | Bile Arisaema should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and heat sources. Keep the container tightly closed to prevent moisture absorption and contamination. Avoid storing with incompatible or odorous substances. Label clearly and store out of reach of children. Follow local regulations and safety standards for handling medicinal or chemical substances. |
|
Purity 98%: Bile Arisaema with 98% purity is used in pharmaceutical formulations, where it ensures high bioactivity and consistent therapeutic outcomes. Particle Size 10 μm: Bile Arisaema with a particle size of 10 μm is used in tablet manufacturing, where it promotes uniform blending and enhanced dissolution rates. Viscosity Grade 120 cP: Bile Arisaema of 120 cP viscosity grade is used in injectable suspensions, where it provides optimal flow properties and stable dispersion. Melting Point 150°C: Bile Arisaema with a melting point of 150°C is used in heat-processed formulations, where it maintains chemical integrity during processing. Stability Temperature 40°C: Bile Arisaema stable at 40°C is used in shelf-stable drug products, where it ensures prolonged product efficacy under storage conditions. Moisture Content ≤2%: Bile Arisaema with moisture content ≤2% is used in lyophilized pharmaceuticals, where it prevents agglomeration and extends shelf life. Solubility 30 mg/mL: Bile Arisaema soluble at 30 mg/mL is used in liquid oral solutions, where it enables high-dose delivery and rapid patient absorption. Assay ≥99%: Bile Arisaema with assay ≥99% is used in quality-controlled clinical studies, where it guarantees accurate dosing and reproducibility of results. Bulk Density 0.65 g/cm³: Bile Arisaema with bulk density of 0.65 g/cm³ is used in capsule filling, where it allows precise volumetric measurement and uniform dosage units. pH Stability 5–8: Bile Arisaema stable in pH 5–8 is used in gastrointestinal targeted drugs, where it preserves activity throughout varying pH environments. |
Competitive Bile Arisaema prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing Bile Arisaema in our facility is the result of hands-on effort and years of refinement. Unlike most plant-based extracts, Bile Arisaema presents a set of challenges—from sourcing mature arisaema roots, to ensuring readiness of the bile, and fine-tuning temperature and humidity during processing. As a chemical manufacturer, we know the importance of controlling every step, not just for compliance with pharmacopeia standards but for real-world reliability. The manufacturing journey relies on exacting separation, repeated purification, and techniques that keep the active compounds stable. Through careful control of source herb quality and bile fermentation, we've solved problems others often overlook, such as risk of enzymatic degradation or uneven product strength. For specialists, the difference shows up in performance and consistency lot after lot.
Bile Arisaema comes in refined powder and granule forms, both designed for laboratory and pharmaceutical integration. Our established models reflect specifications that have proven most useful for research and production lines. For instance, Model AR-BX80 features a finely milled powder—aimed at rapid dissolution where particle size makes a difference for absorption studies or pre-formulation testing. Model AR-GRA17 delivers a coarser granule, preferred where controlled release or blending into solid formats takes priority. During manufacture, we keep moisture content tightly regulated to avoid clumping or microbial contamination, and package using inert-gas environments for the powder model. Unlike smaller outfits, every lot undergoes batch testing—appearance, solubility, heavy metal content, residual solvent analysis, and standardized reference marker compounds.
Years ago, labs noticed inconsistent results using market-sourced Bile Arisaema—the bioactive profile bounced around with each lot. Quality comes down to the roots and the fermentation, which sounds simple but rarely is. The arisaema roots can't just be fresh from any source. They need the right age, harvested at peak maturity, and carefully washed and prepared before processing. Bile itself must meet pharmacopoeial grade, with the right enzymatic content. Mixing, temperature, and humidity have their place, but overlooked variables—such as the microflora present in fermentation or subtle differences in feedstock—make profound impacts. By running continuous monitoring and keeping small-scale trial runs before each big batch, we’ve managed to keep active constituent levels steady, year in and year out.
Comparing Bile Arisaema from our line to common commercial varieties exposes the nature of actual manufacturing. Some vendors sell repackaged third-tier powder, sometimes with inconsistent aroma and color. We field calls from researchers frustrated by residue in their filtrates or off-odors showing up during blending, often traced to inconsistent fermentation or inferior arisaema starting material. By producing in-house, we ensure no addition of fillers or synthetic dyes, and we avoid batch-to-batch drift seen in commodity powders purchased from intermediaries. The result is a stable, true-to-source product, which holds up under full-spectrum analysis and matches reference standards on every new lot. For industrial buyers, this predictability removes a source of troubleshooting later on.
From our experience supplying bulk Bile Arisaema, real value comes from reliability. Scientists in pharmaceutical R&D rely on predictable solubility and measured marker levels, not just qualitative confirmation. When creating traditional formulas or modern health supplements, formulating with inconsistent powder means extra work and re-testing—time lost every production cycle. We’ve watched customers shift to our material mid-project after stability problems with cheaper alternatives. By offering full traceability—from collected root to final package—batch records clarify every detail, and our internal documentation supports downstream compliance, especially for projects moving toward regulatory approval.
Our facility handles every process onsite, from reception and primary processing to final blending and packaging. This vertical integration isn't just a talking point. During busy seasons, outsourcing even part of the process would make control slip and invite cross-contamination or moisture issues. Instead, equipment is dedicated and continuously monitored. Onsite quality labs test incoming roots for mycotoxins and pesticide residues, criteria that are often skipped by resellers. Solvent handling happens on closed systems with automated ventilation tracking, meeting pharmaceutical-grade working environments rather than informal blending in open rooms. This method isn’t quick or cheap, but it's proven more sustainable for consistent, high-quality supplies.
Relying on specialty agricultural raw materials always brings risk. Crop failures can spike prices, and shortages of bile or arisaema occasionally hit the market. With established supplier relationships and inventory reserves, we shield our customers from having their formulations interrupted by raw material shocks. Yearly contracts for arisaema root harvests stabilize the supply chain. Bile procurement often faces scrutiny from regulatory authorities, but by purchasing only from licensed operations and testing incoming lots for contaminants, we prevent supply issues from passing down the line. These steps help avoid hidden costs later—like rejected batches or gaps in product timelines.
Each production lot starts with barcode tracking from raw material intake through finished product release. Before roots are sliced or mixed, our team inspects for physical defects, foreign materials, or signs of rot that could compromise the final batch. Fermentation relies on microbiological control, and samples are pulled every few hours to check pH, temperature, and yeast content. The finished lot receives full HPLC analysis for active compounds, total ash content, and heavy metals—including arsenic, lead, and cadmium. Many smaller outfits promise the same thing, but often send out certificates copied from previous lots or outside labs. On our site, each batch faces new testing and those reports stay on file, linked directly to each outgoing shipment.
Users come to us after running into persistent headaches elsewhere. They might find themselves reworking lots because of impurities or batch-to-batch drift they can't explain. By sharing our own validation protocols—including detailed USP/EP test results—we've helped partners troubleshoot issues far outside of our product line. We encourage site visits and audits, wherever possible, setting us apart from resellers who simply hand over pre-packed powder without supporting data. By working directly with formulation teams, our feedback cycle shortens and product improvements happen faster.
Our minimum batch sizes aren’t just calculated for convenience—they match the equipment scale required for uniform fermentation and complete conversion of raw components. Small-scale test lots ensure process controls hold up before ramping to production quantity. Some manufacturers push very small or extremely large batches, seeing cost alone as the factor. We learned that too-small batches risk incomplete fermentation, while oversized lots sometimes lack even drying. By matching batch size to process design, we stabilize finished content and reduce risk of loss, letting customers plan their own schedules with confidence.
Bile Arisaema’s bioactive compounds—most notably aristolactam derivatives and secondary alkaloids—are subject to oxidation and enzymatic breakdown where temperature goes unchecked. Over the years, we've charted stability curves at each processing step, adjusting drying rates and humidity thresholds for each new harvest. Early studies on powder lots from the open marketplace showed frustrating losses in activity after a few months in storage. Our method of blending, vacuum-packing, and storing under controlled conditions pushes stability well beyond the typical shelf-life researchers expect.
Industry standards continue to move, with regulators setting lower thresholds for trace contaminants and tighter controls over raw material traceability. By taking a manufacturing-first approach, our compliance team works ahead of new requirements—it isn’t about chasing old standards, but anticipating new limits. Records for every ingredient batch support product registrations moving into tough foreign markets, an advantage for global brands unable to rely on generic powders from the open market. Our lot records include not only the basics—origin, date, lot code—but full processing notes and any deviations observed and resolved in real-time.
Many clients today want more than sample test reports—they seek full transparency for their regulatory filings and quality checks. During production we allow both screen and in-person access to test results as they become available. Our staff welcomes either virtual or on-site audits, and we regularly review results with partners during the onboarding process. Some companies hide behind imported documentation with little clarity on process steps or actual quality data. Instead, we openly share our real batch histories and invite external labs to run their own confirmation tests on retained samples, a practice only possible for those with direct control over production lines.
Once in a finished formula, Bile Arisaema’s background becomes clear through traceability and real-world feedback. A health supplement brand finds distinctive aroma and blending properties reflect true source material, not bulk carrier added to stretch cost. Pharmaceutical R&D groups report less lot rejection during validation and easier compliance with market registration. Technical partners replacing off-the-shelf powders have seen reduced loss in final blends and less back-and-forth to solve blend or flow problems. Over multiple years, client feedback has proven there’s tangible value in handling all critical steps in-house.
Bile Arisaema research benefits from process data and transparent support unavailable from generic distributors. Our technical teams cooperate directly with R&D groups to provide detailed composition data, shelf-life studies, and assistance in regulatory application. On request, we supply reference standards from our own archives for method development, something bulk resellers cannot match. Collaborative projects build from this openness—several academic groups have refined their experimental design after reviewing our long-term lot stability data.
Over the past decade, our approach has shifted as new findings on extraction, fermentation, and blending techniques emerge. Modern analytics have provided ways to monitor active marker compounds faster and with greater precision. This means we can adapt process parameters on the fly, dialing in the final profile to suit updated client requirements. Importantly, our dedicated lines prevent risk of cross-contamination with unrelated botanicals or chemicals, which is especially important for pharmaceutical clients concerned about even minute traces of foreign material.
Large-scale agricultural extraction and fermentation can introduce environmental risks—wastewater, solvent residues, and raw material wastage. Our upgrade to closed-loop water systems and solvent recovery has reduced both the environmental burden and long-term cost. Plant waste returns as fertilizer to contracted farms, while careful monitoring and reporting support both local and international environmental requirements. This not only limits liability but preserves essential supplier relationships, further stabilizing the supply chain.
Real improvement comes by responding to feedback from those using Bile Arisaema day-in and day-out. We schedule regular meetings with our largest clients and leading development partners, with feedback driving rapid testing of new process tweaks. Some of our best improvements—faster dissolution curves, improved color quality, and reduced residue in filtrates—grew out of customer concerns. By owning production end-to-end, these adjustments reflect in new lots almost immediately, whereas distributed models might take multiple cycles to catch up.
Finished Bile Arisaema departs our plant in moisture-resistant, lightproof packaging custom-engineered for the specific lot size. By adding oxygen scavengers and inner-seal lining, we maintain freshness throughout transport. Each unit is batch-marked for traceability. Deliveries sequence in coordination with major pharmacy and supplement schedules, reducing storage times at customer warehouses and preserving product potency better than bulk market products with unclear dating.
Building product quality from raw field through to end-user matters more than branding in a crowded chemical market. As direct manufacturers, we see the issues that show up post-sale: flaking, clumping, or dustiness traced to improper transport or long storage. Regular feedback enables us to tweak packaging, refine moisture barriers, and offer support for distributors facing regulatory or customs slowdowns. By closing this loop, we make Bile Arisaema simpler to use and more predictable in real-world, high-stakes formulation settings.
Bile Arisaema serves both traditional roles and modern scientific exploration. New extraction protocols and tighter safety standards keep the field moving. With our direct control over supply, process, and documentation, we help lead this evolution. For end users, this means less risk, more data, and a smoother road from purchase to finished product—objectives we treat as non-negotiable in the daily running of our manufacturing line.